Skip to content
Treatments

HRT after hysterectomy: estrogen alone, your ovaries, and what the research found

HRT after hysterectomy: why most women can take estrogen alone, what the WHI estrogen-only trial found on breast cancer, and what surgical menopause means.

  • Hysterectomy
  • Estrogen
  • Hormone therapy
Written by WarriorBabe Health Editorial TeamPublished · Updated · 8 min read
An older woman with white hair and a younger woman hugging and laughing in a garden
In this article

A hysterectomy changes the hormone therapy conversation. Without a uterus, one of the main reasons for adding progesterone falls away, and a different body of research applies to you. Whether your ovaries were removed matters too. This guide covers estrogen-only therapy, what the Women's Health Initiative found in women who had a hysterectomy, and what to know if surgery brought on menopause early.

Hysterectomy, ovaries, and menopause

A hysterectomy is surgery to remove the uterus. All or part of the uterus may be removed, and the fallopian tubes and ovaries may be removed at the same time [5]. Removing both ovaries is called a bilateral oophorectomy.

The difference matters for your hormones. A hysterectomy causes menopause if your ovaries are also removed [5]. The Menopause Society explains that surgically removing both ovaries brings a much more abrupt loss of estrogen and progesterone than natural menopause, along with a significant drop in testosterone [1]. Hot flashes and other symptoms tend to be more frequent and more severe after oophorectomy [1].

If your ovaries were kept, a hysterectomy on its own does not cause menopause [5]. Without periods, though, it can be harder to tell when menopause arrives. Your clinician can help you sort out whether new symptoms are hormonal.

Why estrogen alone is usually enough

Estrogen makes the lining of the uterus grow. In women with a uterus, estrogen on its own raises the risk of endometrial hyperplasia and cancer, so a progestogen is added to protect the lining [1]. Without a uterus, that reason is gone. FDA labels say that, generally, a woman without a uterus does not need a progestogen in addition to her estrogen [6, 7].

There is an important exception. The Vivelle-Dot label notes that some women who have had a hysterectomy and have a history of endometriosis may need a progestogen [6]. The estradiol tablet label explains why: a few cases of cancer developing in leftover endometriosis tissue have been reported in women taking estrogen alone after hysterectomy, so adding a progestin should be considered for women known to have residual endometriosis [7]. If you had endometriosis, tell your clinician.

You may notice that systemic estrogen-only labels still carry a boxed warning about endometrial cancer. In 2025, when the FDA asked makers to remove several boxed warnings from hormone therapy labels, it kept the endometrial cancer warning on systemic estrogen-alone products [8]. That warning concerns the uterine lining, which is why it matters for women who still have a uterus [1]. For more on when progesterone is and is not needed, see can you take progesterone without estrogen?

What the WHI estrogen-alone trial found

Most HRT headlines come from the Women's Health Initiative's estrogen-plus-progestin trial. The WHI also ran a separate trial just for women who had already had a hysterectomy, and its results were different.

That trial enrolled 10,739 postmenopausal women aged 50 to 79 who had a prior hysterectomy, at 40 US centers [2]. They took either 0.625 mg a day of conjugated equine estrogen, an older type of estrogen pill, or a placebo [2]. The National Institutes of Health ended the treatment phase early in 2004, after an average of 6.8 years [2].

WHI estrogen-alone trial in women with a hysterectomy, compared with placebo
OutcomeWhat was found
Coronary heart diseaseNo effect during treatment [2]
StrokeHigher risk: 12 more strokes per 10,000 women per year [2]
Hip fractureLower risk: 6 fewer hip fractures per 10,000 women per year [2]
Breast cancer during treatmentFewer cases, though not statistically significant [2]
Breast cancer after about 20 yearsFewer diagnoses and fewer deaths [3]
Deaths from any causeNo overall effect [4]

The breast cancer finding

This is the result that surprises most women. After more than 20 years of follow-up, women who had taken estrogen alone had significantly fewer breast cancer diagnoses than women on placebo: 238 cases compared with 296 [3]. They also had fewer breast cancer deaths, 30 compared with 46 [3]. In contrast, women with a uterus who took estrogen plus a synthetic progestin had more breast cancer diagnoses than placebo [3].

Keep two things in mind. The trial tested one specific estrogen pill, not the estradiol most women use today [2]. And large observational studies have found that breast cancer risk rose with longer use of estrogen alone, which The Menopause Society notes differs from the WHI trial result [1]. Your personal and family history still matter.

Age made a difference

Women who started estrogen alone in their 50s had more favorable results for overall mortality, heart attack, and a combined index of risks and benefits than older women [4]. For women aged 50 to 59, the researchers estimated 19 fewer adverse events per 10,000 women each year on estrogen alone, compared with 51 more for women aged 70 to 79 [4]. The WHI investigators concluded that hormone therapy should not be used to prevent chronic disease, but may be appropriate for managing symptoms in some women [4].

If your ovaries were removed before menopause

Losing your ovaries early is not the same as reaching menopause at the usual age. The Menopause Society reports that oophorectomy is linked to higher risks of heart disease, cognitive problems and dementia, low bone density, and sleep problems [1]. Removal before age 40 is linked to higher rates of heart disease and several other conditions [1]. Some of these risks appear to be lower with estrogen therapy in observational studies [1].

That is why the guidance is different for this group:

  • Estrogen is recommended unless there is a reason not to. The Menopause Society says estrogen therapy is indicated for women who had both ovaries removed before the average age of menopause, to treat hot flashes, improve bone density, and lower osteoporosis risk [1].
  • Continue at least until about 52. For premature or early menopause, which means before age 45 and includes menopause caused by surgery, hormone therapy is recommended at least until the average age of menopause, approximately 52 [1].
  • Doses may need to be higher. Younger women may need higher doses to relieve symptoms and protect bone [1].
  • WHI results do not apply. The Menopause Society says the WHI findings in older women do not apply to women with premature or early menopause [1].

FDA labels reflect this too. Estradiol tablets are approved to treat low estrogen caused by removal of the ovaries, with a usual starting range of 1 to 2 mg a day adjusted to symptoms [7]. MedlinePlus advises discussing estrogen replacement therapy with your provider after a hysterectomy [5].

Who should not take estrogen

Not having a uterus does not remove every reason to avoid estrogen. The Menopause Society lists these as reasons not to use oral or transdermal hormone therapy [1]:

  • Liver disease
  • A past estrogen-sensitive cancer, including breast cancer
  • Past coronary heart disease, stroke, heart attack, or blood clot
  • A personal or inherited high risk of blood clots

Your clinician will review your full history. For a broader look at risk, read is HRT safe?

Choosing a form of estrogen

Estrogen-only therapy comes in several forms, including pills, patches, gels, sprays, and vaginal rings [1]. Non-oral routes skip the liver's first pass, and observational studies suggest less clot risk with transdermal estrogen than oral, though randomized trials comparing them are lacking [1]. Our guide to estradiol pill vs patch walks through the trade-offs.

Estrogen after hysterectomy at WarriorBabe Health

WarriorBabe Health offers estrogen as an estradiol patch, an oral estradiol tablet, and an estradiol cream for the skin. If you have had a hysterectomy, your clinician will ask whether you had endometriosis and whether your ovaries were removed, then decide whether estrogen alone fits you. See all options on our hormone treatments page.

Our products are compounded by a licensed pharmacy. Compounded drugs are not FDA-approved, and the FDA does not review their safety, effectiveness, or quality before they are marketed [9]. FDA-approved estrogen products also exist. Ask your clinician which option suits you, and take the 2-minute quiz to start.

Frequently asked questions

Do I need progesterone after a hysterectomy?

Usually not. A progestogen is added to estrogen mainly to protect the uterine lining, and FDA labels say a woman without a uterus generally does not need one [6, 7]. The exception is some women with a history of endometriosis, who may still need a progestogen [6, 7].

Is estrogen-only HRT safer than combined HRT?

The risks are different. In the WHI, estrogen alone in women with a hysterectomy was linked to fewer breast cancer diagnoses and deaths over about 20 years, while estrogen plus a synthetic progestin was linked to more diagnoses [3]. Estrogen alone did raise stroke risk during treatment [2]. Your age and health history shape your own balance of risks [4].

I had my ovaries removed at 44. How long should I take estrogen?

The Menopause Society recommends hormone therapy, unless there is a reason not to, at least until the average age of menopause, about 52 [1]. After that, you and your clinician can reassess. Younger women may need higher doses than women who start at the usual age of menopause [1].

Will a hysterectomy put me into menopause?

Only if your ovaries are removed too. MedlinePlus notes that a hysterectomy causes menopause if the ovaries are also removed [5]. If your ovaries were kept, you reach menopause on your own timeline, although you will no longer have periods to signal it.

Does estrogen alone after hysterectomy raise breast cancer risk?

In the WHI trial of women with a hysterectomy, estrogen alone was linked to fewer breast cancer diagnoses than placebo after more than 20 years of follow-up [3]. Large observational studies, however, found risk rose with longer use of estrogen alone [1]. Talk with your clinician about your personal and family history.

References

  1. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. menopause.org/wp-content/uploads/professional/nams-2022-hormone-therapy-position-statement.pdf
  2. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701-1712. pubmed.ncbi.nlm.nih.gov/15082697/
  3. Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women's Health Initiative randomized clinical trials. JAMA. 2020;324(4):369-380. pubmed.ncbi.nlm.nih.gov/32721007/
  4. Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013;310(13):1353-1368. pubmed.ncbi.nlm.nih.gov/24084921/
  5. Hysterectomy. MedlinePlus Medical Encyclopedia. US National Library of Medicine. Reviewed 03/2026. medlineplus.gov/ency/article/002915.htm
  6. Sandoz. Vivelle-Dot (estradiol transdermal system) prescribing information. DailyMed, US National Library of Medicine. Revised 11/2023. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5ccb77f9-d47b-4381-ad5c-5b92524e1c4a
  7. Teva Pharmaceuticals USA. Estradiol tablets, USP, prescribing information. DailyMed, US National Library of Medicine. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c4936878-1643-4e7f-9b0d-e4957935aef2
  8. US Food and Drug Administration. FDA requests labeling changes related to safety information to clarify the benefit/risk considerations for menopausal hormone therapies. November 10, 2025. www.fda.gov/drugs/drug-alerts-and-statements/fda-requests-labeling-changes-related-safety-information-clarify-benefitrisk-considerations
  9. US Food and Drug Administration. Understanding the risks of compounded drugs. www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs

This article is for general information. It is not medical advice and does not replace a visit with a licensed clinician who knows your history. Do not start, stop or change a medication without talking to your clinician. If you think you are having a medical emergency, call 911.

Keep reading